Skip to main content

Table 1 Clinical and laboratory data

From: Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during hemodialysis treatment

 

Study population n = 12

Sex (M:F)

(8:4)

Age (years)

66.8 ± 8.0

Time in dialysis treatment (years)

4.7 ± 3.4

BMI with dry weight in V-3 (kg/m2)

25.5 ± 2.7

Loss volume per session (l)

2.0 ± 0.5

Hematocrit (%)

36.7 ± 7.3

Hemoglobin (g/dl)

11.9 ± 2.2

Initial fasting blood glucose (mg/dl)

209.4 ± 66.6

Initial glycated hemoglobin (%)

7.3 ± 1.1

Intradialytic blood glucose variation (mg/dl)

52.9 ± 56.9

Hypoglycemia episodes in the 1st week

0

  1. Data presented as mean with standard deviation